Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
experimental group:Self-made Chinese medicine formula + conventional treatment
control group:conventional treatment
Sponsors
People's Hospital of Shijiazhuang
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Confirmed cases who met the diagnostic criteria of the Ninth edition of the COVID-19 diagnosis and treatment protocol and asymptomatic patients who met the Eighth edition of the COVID-19 diagnosis and treatment protocol; 2. Volunteer to participate in the study and sign the informed consent; 3. No age limit, no gender limit. Only those who meet the above two criteria can be included in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with other serious primary respiratory diseases such as lung cancer, severe bronchiectasis, interstitial lung disease, etc.; 2. Serious systemic diseases (e.g., malignancies, autoimmune diseases, hematologic, metabolic, or endocrine diseases) and diseases involving vital organs (heart, brain, liver, kidney) that may affect the evaluation of efficacy; 3. Pregnant or lactating women; 4. Mental disorders, unable to cooperate with the use of drugs; 5. Participated in other clinical trials within 3 months; 6. Allergic constitution or history of traditional Chinese medicine; Those who meet any one of the above will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| negative conversion time of nucleic acid;The negative conversion rate of nucleic acid on the 4th day of admission (the 3rd day of medication);The negative conversion rate was calculated on the 8th day of admission (the 7th day of medication); | — |
Secondary
| Measure | Time frame |
|---|---|
| duration of cough/sputum production/fever;proportion of disease progression;length of stay;blood indicators;Circulation threshold;Lung CT; | — |
Countries
China
Contacts
Public ContactYubin Zhao
People's Hospital of Shijiazhuang
Outcome results
None listed